Royalty Pharma plc (NASDAQ:RPRX) Q4 2025 Earnings Call Transcript February 11, 2026 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.47, expectations were $1.33. Operator: Ladies and ...
Portfolio Receipts of $874 million in Q4 2025 and $3,254 million for FY 2025 Portfolio Receipts growth of 18% in Q4 2025 and 16% for FY 2025 Net cash provided by operating activities of $827 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results